Opaleye Management Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2019$8,001,000
+3.7%
100,000
-4.8%
1.57%
-43.7%
Q3 2019$7,714,000
-34.6%
105,000
-16.0%
2.79%
-22.4%
Q2 2019$11,791,000
+13.3%
125,000
-3.8%
3.59%
+24.7%
Q1 2019$10,407,000
-35.7%
130,000
-56.7%
2.88%
-52.2%
Q4 2018$16,173,000
-30.9%
300,0000.0%6.04%
+1.3%
Q3 2018$23,418,000
+5.4%
300,000
-14.3%
5.96%
+3.6%
Q2 2018$22,218,000
-59.6%
350,000
-41.7%
5.75%
-63.4%
Q1 2018$55,020,000
-0.7%
600,000
-18.4%
15.73%
-11.4%
Q4 2017$55,426,000
+8.2%
735,0000.0%17.75%
-2.0%
Q3 2017$51,207,000
+14.8%
735,000
-16.5%
18.11%
-2.8%
Q2 2017$44,589,000
+26.7%
880,0000.0%18.62%
+6.3%
Q1 2017$35,191,000
+42.6%
880,0000.0%17.51%
+20.4%
Q4 2016$24,684,000
+5.9%
880,000
+12.1%
14.54%
+19.2%
Q3 2016$23,315,000
+360.5%
785,000
+214.0%
12.20%
+260.8%
Q2 2016$5,063,000
+27.5%
250,000
+13.6%
3.38%
+36.6%
Q1 2016$3,971,000
-45.2%
220,000
-20.0%
2.48%
-18.3%
Q4 2015$7,244,000
+161.1%
275,000
+111.5%
3.03%
+121.9%
Q3 2015$2,774,000130,0001.36%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders